[Loss of CD23 expression after bortezomib plus dexamethasone therapy in CCND1/IGH-positive multiple myeloma].
Year: 2013
Type: article
Study design: Case Report
Source: PubMed
Authors: Akihito Fujimi, Akari Hashimoto, Yuji Kanisawa, Toshinori Okuda, Shinya Minami, Tadashi Doi, Teppei Matsuno, Kazuma Ishikawa, Naoki Uemura
Institution: Oji General Hospital
Language: Japanese
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W49494647
